Join our newsletter to stay up to date on cases and settlements.
Depo Provera faces legal scrutiny as cases arise linking the birth control drug to increased brain tumor risks. You may be entitled to compensation, if you have developed Cerebral Meningioma (Malignant or Benign).
Last Update
A recent study from the University of British Columbia has strengthened claims in the Depo-Provera brain tumor litigation. Researchers analyzed data from over 319,000 contraceptive users and found that women using Depo-Provera for over one year had a 3.55-fold increased risk of developing intracranial meningioma compared to those using EE-LNG, a common oral contraceptive. The study corrected limitations of earlier research by including an active comparator, adjusting for disease latency, and analyzing a larger sample size. With an estimated one in 1,111 users affected, the findings highlight significant safety concerns and labeling failures linked to Depo-Provera use.
A Utah plaintiff has filed suit in the Depo-Provera multidistrict litigation, alleging severe injury linked to long-term use of the contraceptive injection. She received Depo-Provera from 1996 to 2006 and was later diagnosed with a WHO Grade II-III intracranial meningioma at age 31, following worsening headaches. A craniotomy was performed in 2008. The plaintiff claims she did not discover the connection between the drug and her tumor until late 2024, citing recent scientific findings. She argues that inadequate warnings prevented informed decision-making, forming the basis for her claims for compensatory and punitive damages.
A newly filed complaint in the MDL introduces a Florida plaintiff who claims she developed a symptomatic intracranial meningioma affecting her hearing following Depo-Provera injections received in the early 2000s. The complaint states she began experiencing bilateral sensorineural hearing loss and tinnitus in 2019, leading to an MRI that identified a brain tumor. The tumor was subsequently linked to her prior Depo-Provera use.
Judge Rodgers' latest order has clarified the status of authorized generics Greenstone, Viatris, and Prasco in the litigation. After reviewing submitted affidavits—which the court accepted in lieu of early depositions—the judge determined the case will proceed without delay, while preserving plaintiffs' right to challenge the generics' involvement as discovery continues. Notably, plaintiffs are nearing a stipulation that would dismiss Prasco from the case, though similar resolutions appear unlikely for Greenstone and Viatris. These remaining defendants must continue discovery discussions but will face full participation in the litigation process if no agreement is reached. The ruling marks progress for plaintiffs, maintaining Greenstone and Viatris as active defendants while allowing evidence collection about their alleged role in marketing and distributing the subject drug.
Depo Provera was once a popular birth control choice for women seeking long-term contraception without the inconvenience of taking daily pills. However, disturbing claims have recently started to surface that the birth control injections can lead to the development of brain tumors.
As more women face the diagnosis of brain tumors after using Depo Provera, many are coming forward, claiming that they were never told about the risks associated with the drug.
Depo Provera (depot medroxyprogesterone acetate), manufactured by Pfizer, is an injectable form of birth control that relies on progestin. It works by slowly releasing the hormone to prevent ovulation for 12 to 14 weeks between injections.
Often referred to as the “Depo Shot”, the injection is administered by a healthcare professional into the muscles of the arm or buttocks. Many women relied on this convenient option, trusting that it was safe for long-term use.
The problem lies in the alleged connection between Depo Provera and meningiomas, which are tumors that form on the brain and spinal cord. Recent studies have suggested a link between prolonged use of Depo Provera and an increased risk of developing brain tumors.
Despite these potential dangers, Pfizer is accused of failing to warn the women using the birth control method of the possible risks. Women who took Depo Provera for extended periods may have unknowingly exposed themselves to these risks. Many are now facing serious health consequences.
The primary concern associated with Depo Provera is its link to meningioma tumors. Although meningioma brain tumors are often benign, they can still cause significant health problems due to their location.
In many cases, meningioma tumors may require surgery. They can also lead to other complications like headaches, vision problems, or even seizures.
Women who took Depo Provera for years are now dealing with these life-altering conditions, and they’re looking for answers.
Around the world, millions of women have used Depo Provera and generic versions to prevent pregnancy since approval in 1992 by the U.S. Food and Drug Administration (FDA).
A study released in March 2024 and carried out by the British Medical Journal (BMJ) found that women who used Depo Provera were 5.6 times more likely to develop a brain tumor.
Reports show that the risks associated with Depo Provera and the development of brain tumors have been submitted to the FDA for decades. The data also shows that incidences of brain tumors are continuing to increase. Despite the reports, Pfizer failed to warn women about the potential risks.
The main claims in the Depo Provera lawsuits include:
To pre-qualify, you must have used Depo-Provera, Depo-SubQ Provera, or an authorized generic form of medroxyprogesterone acetate at least twice after 1992.
You must have also been diagnosed with meningioma or a brain tumor at least 2 years after your first shot.
Factors like the length of Depo-Provera use, the time between the last use and your diagnosis, as well as the type of brain tumor or meningioma diagnosed, will also be considered. You will need to speak to a lawyer about the specifics of your case.
As more women learn about the possible dangers of Depo Provera, lawsuits are being submitted across the country. Many of these lawsuits claim that Pfizer failed to adequately warn women about the risks of developing meningiomas.
Women who used Depo Provera are seeking compensation for medical expenses, lost wages, pain and suffering, and other damages related to their diagnoses. The goal of the plaintiffs is to hold Pfizer accountable for the harm caused by their product.
If you took Depo Provera and later developed a brain tumor, you may be eligible to join a class action lawsuit.
Your first step should be to consult with your doctor to discuss your use of Depo Provera and determine if your health problems are linked to the use of injectable birth control.
If you’ve been diagnosed with a brain tumor, you may be able to pursue financial compensation. First, you’ll want to gather your medical records, including documentation of your Depo Provera use and your diagnosis.
If you or a loved one has been affected by Depo Provera, now is the time to take action. Thousands of women are seeking justice for the harm they’ve suffered, and you may be entitled to compensation.
Joining a class action lawsuit is about more than obtaining a settlement. It’s also about holding Pfizer accountable for the safety of the products they sell.
The potential dangers of Depo Provera have left many women feeling betrayed and uncertain about their future and health.
If you’ve taken Depo Provera and are now facing health issues, you’re not alone. Class action lawsuits offer a way to seek justice and compensation for the suffering and associated risks of using Depo Provera.
Don’t wait. Consult with your doctor, explore your legal options, and take steps to protect your rights. We encourage you to start the process of finding out if you may qualify for a Depo Provera class action lawsuit. We can help you stay informed and provide you with the latest updates regarding the lawsuit. Subscribe to OnlyClassActions for further details.
This is an advertisement. OnlyClassActions is not a law firm or referral service, and we do not provide legal advice. OnlyClassActions provides a free service for individuals seeking legal representation, and we do not charge you to be connected with an attorney. We do not recommend or endorse any attorneys that pay to participate. OnlyClassActions utilizes a pool of attorneys in each jurisdiction, and attorneys are selected through a round-robin process without our evaluating your legal situation when selecting which attorney will receive your information. OnlyClassActions makes no representation about the quality of legal services or the qualifications of any attorney participating in our pool. Information you submit will be shared with third-party attorney(s). An attorney-client relationship is not formed when you submit information through the form. Hiring a lawyer is a critical decision and should not be predicated solely on comments, advertisements, or other content found on any website. You are under no obligation to retain a lawyer who contacts you through this service.
Add Comment